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Variables Overall 2003 2009 P
Surgical outcomes
Return to OR 14% 16% 7% .0001
Blood transfusion 2 U 5% 8% 3% .041
Wound infection 5% 5% 3% .026
1-year amputation-free survival 94/79% 94/81% 92/78%a NS
1-year graft patency (claudication/
CLI)
91/84% 89/85% 95/90%a NS
1-year limb salvage (claudication/
CLI)
98/89% 99/89% 94/88%a NS
aValues used from 2008 to allow for capture of 1-year outcomes.
Outcomes Following Endovascular Intervention for Chronic Critical
Limb Ischemia by Rutherford Classification
Maciej L. Dryjski, MD, PhD, Monica O’Brien-Irr, MS, RN, Linda Harris,
MD, and Hasan Dosluoglu, MD, Kaleida Health, Buffalo, NY
Objective: This study evaluated outcomes after endovascular interven-
tion (EVI) for chronic critical limb ischemia (CLI) by Rutherford class
(RC4: rest pain; RC5: tissue loss).
Methods: The medical records of all EVI performed for RC 4-5 by
vascular surgeons at a single institution during a 3-year period were
reviewed for the following outcomes. Sustained clinical success (SCS)—
Rutherford Improvement Score (RIS): 2, without target extremity
revascularization (TER). In RC5 patients, patency until healing; healing
4 months without recurrence or new ulceration. Secondary sustained
clinical success (SSCS)—RIS: 2 with TER. In RC5 patients; patency
until healing; healing at any time during follow-up, without recurrent or
new ulceration. Data were analyzed using SPSS. Significance was estab-
lished at the 0.05 level.
Results: Of 106 EVI performed, 78 (74%) were RC5. There were 39
men (37%). Mean age was 73 12. Mean follow-up was 19 months (range,
1-44). Table I: Significant differences between RC4 and RC5 were found.
Outcomes were significantly better for RC-4. Table II: Independent predic-
tors of failure of SCS and SSCS in RC5 are shown: Table III. SSCS in RC5
patients with DM and CHF was 11%, 33% when either CHF or DM were
present and 72% when neither were present (P  .009).
Conclusions:Outcome after EVI for RC4 was significantly better than
for RC5, favoring early intervention. Limb salvage was acceptable in RC5
yet, SCS (early wound healing without TER) occurred in only 21%. Diabetes
and CHF were predictors of poor SSCS. Careful selection of patients may
improve outcome in RC5.
Table I.
RC Distal EVI DM Dialysis Current smoker
RC4 29% 32% 0% 57%
RC5 53% 58% 14% 32%
P .029 .020 .036 .023
Table II.
RC 24-mon survival 24-mon limb salvage SCS SSCS
RC4 84%  8% 100% 48% 85%
RC5 62%  7% 83%  4% 21% 39%
P .09 .026 .006 .001
Table III.
Outcome
Independent
predictor Odds ratio
Confidence
interval P
SCS DM 3.76 1.04—13.69 .04
SSCS DM 4.69 1.42—15.63 .011
SSCS CHF 4.07 0.99—16.67 .05Lesion and Device Characteristics That Predict Distal Embolization
During Percutaneous Lower Extremity Interventions
Gautam V. Shrikhande, MD,HafizHussain, MD, Sikander Khan,MD, Rajeev
Dayal, MD, Katherine Gallagher, MD, James F. Mckinsey, MD, and Nicholas
Morrissey, MD, Columbia University Medical Center, New York, NY
Objectives: Distal embolization (DE) during percutaneous lower ex-
tremity revascularization (LER)may cause severe clinical sequelae. To better
define DE, we investigated which lesion characteristics and treatment mo-
dalities increase the risk for embolization.
Methods: A prospective registry of LER from 2004-2009 was re-
viewed. All cases with runoff evaluated before and after intervention were
included. Angiograms and operative reports were reviewed for evidence of
DE. Rates of DE were analyzed with 2, and outcomes were analyzed by
log-rank analysis. The study included 2137 lesions.
Results: Tables I and II report DE rates for lesions/modalities. DE
rate was unchanged by runoff status and did not affect limb salvage. In 32 of
34 cases of DE, patency was restored before leaving the OR.
Conclusions: DE is a rare event that occurs more often with CSI and
Pathway devices. In-stent and complex native lesions are at higher risk for
DE. DE has no effect on limb salvage and is typically reversible with
endovascular techniques.
Scientific Session VI
Simultaneous TEVAR and EVAR is Feasible with Minimal Morbidity
and Mortality
Melissa L. Kirkwood, MD, Alberto Pochettino, MD, Ronald M. Fairman,
MD, Benjamin M. Jackson, MD, Joseph E. Bavaria, MD, and Edward Y.
Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, Pa
Objective: To determine the results of simultaneous TEVAR and
EVAR.
Methods: Records were retrospectively reviewed. Seven patients (5
men; mean age, 73 years) underwent simultaneous TEVAR and EVAR
between 1999-2009 at a single center. All patients had concomitant thoracic
and abdominal aneurysms. The average diameters of the thoracic and
abdominal aneurysms were 6.6 and 6.3 cm, respectively. Three patients were
treated emergently, and the remainder had urgent indications for simulta-
neous repair. All patients had significant comorbidities (HTN, CAD, CHF,
smoking, COPD).
Results: Average procedural time was 165 minutes. Spinal drainage
and neuromonitoring was used in all cases. TEVAR was performed before
Table I. Incidence of distal embolization based on
treatment modality
Intervention Lesions Distal embolization
No. No. (%)
PTA 570 5 (0.87)
PTA  stent 740 5 (0.67)
Silverhawk ATH 736 14 (1.9)
Newer ATH devices (Pathway, CSI) 36 8 (22.2)a
Laser 55 2 (3.63)
Total 2137 34 (1.59)
aIndicates P  .05 compared with PTA.
Table II. Embolization by lesion type and TASC
Variable Lesions Distal embolization
No. No. (%)
Lesion type
Stenosis 1334 13 (0.97)
Occlusion 615 15 (2.4)a
In-stent stenosis 188 6 (3.19)a
Total 2137 34 (1.59)
TASC
A/B 929 8 (0.86)
C/D 1208 26 (2.15)a
Total 2137 34 (1.59)
aDenotes statistical significance (P  .05).EVAR. Access was through the common femoral arteries in five patients.
Two patients required direct cannulation of the iliac artery for delivery of the
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required left subclavian coverage, and three patients had full coverage of the
thoracic aorta. Only one patient had internal iliac artery (unilateral) cover-
age. Mean follow up was 22 months (range, 1-72 months), with 100%
survival. No patients developedMI, respiratory failure, or acute renal failure.
The mean preoperative creatinine (1.18  0.16) and mean postoperative
creatinine (1.14  0.22) remained unchanged (95% CI, –0.242 to 0.322; P
 .752). No patients developed neurologic complications, including paral-
ysis or stroke. Mean blood loss was 360  119 mL. There were no access
complications, and all arteriotomies were closed primarily. The average ICU
stay was 3 days, and the average hospital stay was 8 days. In follow-up, one
patient developed a type II endoleak with no intervention due to continued
sac shrinkage.
Conclusion:Combined TEVAR and EVAR can be performed success-
fully with minimal morbidity and mortality. In particular, no patients suf-
fered lower extremity paralysis or renal failure despite a high proportion of
emergent cases.
Root Cause of Fortron Suprarenal Stent Fractures
Jonathon A. Rubin, MD, Zhonghua Li, PhD and Bruce J. Brener, MD,
Newark Beth Israel Medical Center, Newark, NJ
Objective:Clinical experience has revealed that most nitinol AAA stent
grafts suffer from suprarenal stent fracture that could potentially result in
caudal prosthesis migration and/or type I endoleak. There is limited under-
standing of the mechanism of suprarenal stent fracture. The aim of this study
was to investigate the root cause of fracture based on theoretical analysis, in
vitro testing, in vivo image observation, and clinical follow-up.
Methods: Suprarenal stent-to-artery interaction, force translation, ax-
ial motion, and fracture mechanism based on finite element analysis (FEA)
and structural theory were established. In vitro fatigue tests under different
loading modes (axial, radial, twisting, and bending) were performed for 30
devices on Bose ELF and SGT testers with 10 MM cycles. Dynamic CT
imaging data sets were analyzed on 13 patients with AAA devices to observe
and measure specific three-dimensional device deformations and motions
over the cardiac cycle. In addition, clinical follow-up results from the
Fortron AAA stent graft pivotal study were analyzed by a core laboratory.
Results: Bench testing and FEA both indicated that radial pulsatile
torsion and bending did not result in suprarenal stent fracture. However,
1.0-mm axial motion along the aorta could cause fracture anywhere along
the stent frame, 0.5-mm axial motion resulted in one fracture, no fracture
occurred at 0.3 mm, and the estimated minimal threshold was 0.5 mm. FEA
revealed that the axial motion for most AAA patients ranges from 0.37 to
0.49 mm. Dynamic CT imaging, however, showed a maximum axial motion
of 0.9 mm, which exceeded the threshold of 0.5 mm. Clinically, the Fortron
AAA suprarenal stent fracture rate for patients without increased neck
angulations or difficult anatomy at 12 and 48 months were 5.9% (11 of 168)
and 23.2% (35 of 84), respectively.
Conclusions: The suprarenal stent pulsatile axial motion translated from
aorta is the root cause of stent fracture, with implications to suprarenal stent
design.Mitigating axialmotion, increasing stent column strength, and optimiz-
ing the structure to improve its fatigue resistance are the applicable approaches.
Evaluating Preventable Adverse Events: Patient Safety After Elective
Lower Extremity Procedures
Todd R. Vogel, Viktor Y. Dombrovskiy, MD PhD MPH, Paul B. Haser,
Jeffrey L. Carson, MD, and Alan M. Graham, MD, UMDNJ-Robert Wood
Johnson Medical School, New Brunswick, NJ
Objective: Improving patient safety has become a national priority.
Patient Safety Indicators (PSIs) are validated tools to identify potentially
preventable adverse events. No studies exist evaluating lower extremity (LE)
vascular procedures and the occurrence of PSIs.
Methods: The Nationwide Inpatient Sample (2003-2007) was que-
ried for elective LE angioplasty (endo) and bypass (open). PSIs appropriate
to surgery were analyzed by 2 and logistic regression analyses.
Results: A total of 226,501 LE interventions (104,491 endo; 122,010
open) were evaluated. The rate of developing any PSI was 8.51% (endo) and
7.74% (open; P .0001). Adjusted by age, gender, race, and comorbidities,
odds ratios for PSIs are graphed. PSI predictors were age (OR, 1.64; 95%CI,
1.55-1.75), females (OR, 1.18; 95% CI, 1.13-1.22), blacks (OR, 1.10; 95%
CI, 1.04-1.17), congestive heart failure (OR, 1.83; 95% CI, 1.72-1.96),
diabetes (OR, 1.20; 95% CI, 1.12-1.28), renal failure (OR, 2.31; 95% CI,
2.14-2.50), hospital teaching status (OR, 1.21; 95% CI, 1.17-1.26), and
larger hospitals (OR, 1.11; 95% CI, 1.05-1.17). PSI occurrence was associ-
ated with a significant increase in cost ($28,387 vs $13,278; P  .0001).
Conclusions: Although deemed “safer and less invasive,” a greater
number of safety events occurred with endovascular procedures, primarily
due to bleeding complications in women and the elderly. PSIs were associ-
ated with advanced age, black race, and comorbidities. Adverse events added
significant cost and occurredmore frequently in teaching and large hospitals.
Future organizational analysis may improve safety and reduce cost.Patients with Hypertension Have a High Incidence of Peripheral
Arterial Disease Correlating With the Severity of Their Hypertension
David Reznick, MS, John Blebea, MD, John Wang, MD, Michael Smith,
MD, and Eric Yasinow, MD, Case Western Reserve University, Cleveland,
Ohio
Objectives: Although it is well established that patients with peripheral
arterial disease (PAD) have a higher incidence of hypertension (HTN),
studies have not examined if patients with HTN are at higher risk for PAD.
We prospectively investigated the incidence of PAD as a function of the
severity of HTN.
Methods: Patients seen at an internal medicine practice were screened
for the presence of HTN by history, use of antihypertensive medications, or
a blood pressure160/85 mmHg. The number and dose of antihyperten-
sive medications were recorded and patients’ blood pressure and bilateral
ankle-brachial indexes (ABI) were measured.
Results: A total of 116 patients (52 men, 64 women), with a mean age
of 64  2 years and HTN of 14  1 years’ duration, were prospectively
identified. Significant cardiovascular risk factors included hypercholesterol-
emia in 65%, cardiac dysfunction in 33%, smoking in 61% (24  2 pack-
years), renal insufficiency in 40% (creatinine 2.2  0.2 mg/dL), and diabe-
tes mellitus in 34% (HbgA1C 7.2%  0.2%). Mean systolic blood pressure
was 149  3 mm Hg while on three antihypertensive medications. More
than half of the patients, 61%, were still hypertensive with systolic pressures
140 mm Hg, whereas 20% were 160 mm Hg. The mean ABI for the
entire group was 0.98  0.03, with 28% of patients falling 0.90 and an
additional 3% with noncompressible vessels. There was a significant inverse
correlation between the systolic blood pressure and ABI, with higher blood
pressure correlating with a lower ABI (P  .005). Patients with a blood
pressure160mmHg had a significantly lower ABI than those with a lower
pressure, 0.89  0.05 vs 1.02  0.02 (P  .005).
Conclusions: Patients with hypertension have a high incidence of
peripheral arterial disease. The severity of PAD is significantly and propor-
tionately correlated with elevated HTN. Patients with a systolic blood
pressure 160 mm Hg are at particular risk of PAD and should be consid-
ered for further evaluation through measurement of the ABI or vascular
laboratory testing.
Prevalence and Effects of BMI on Hospital Course, 30-Day Mortality,
and Morbidity in Patients Undergoing Endovascular Procedures
Hafiz G. Hussain, MD, Sikandar Z. Khan, MD, Muhammad A. Khan, MD,
Ashley R. Graham, MD, and James F. McKinsey, MD, New York Presbyte-
rian Hospital, New York, NY
Objectives: Obesity is common in patients presenting with vascular
diseases and has been associated with increased perioperative complications
with open surgical procedures, but the effect of body mass index (BMI) on
endovascular procedures is uncertain. This study was to determine the effect
of BMI on hospital course and 30-day mortality and morbidity on patients
undergoing endovascular surgical procedures.
Methods: We identified 2023 endovascular procedures in 1642 pa-
tients (2003-2009) from our prospectively maintained database. These
procedures included 1380 lower extremity revascularizations (LER), 450
endovascular aneurysm repairs (EVAR), and 193 carotid artery stenting
(CAS). Patients were stratified using the WHO classification of obesity into
underweight (BMI 18.5), normal (BMI, 18.5-24.9), overweight (BMI,
25.0-29.9), and obese (BMI30.0). Length of surgery (LOS), PACU stay
(LOP), hospitalization (LOH), amount of blood loss (EBL), 30-day mor-
tality, and morbidity were analyzed using regression analysis
Results: Patient population included 548 normal (35.5%), 48 under-
weight (2.2%), 626 overweight (38.15%), and 385 obese (23.1%). Over-
weight and obese patients had significantly higher diabetes (P 0.001) and
